<p>Superintendencia Nacional de Valores, mediante Providencia N°077 del 19 de julio 2019, autorizó la oferta pública de Obligaciones Quirografarias al Portador no Convertibles en Acciones (Emisión 2019-I) por un monto máximo de Quinientos Millones de Bolívares (Bs. 500.000.000,00) de S.A. Nacional Farmacéutica (SANFAR), de conformidad con lo aprobado en la Asamblea Extraordinaria de Accionistas celebrada en fecha 12 de febrero de 2019.</p>
<p>&nbsp;</p>
<p><a href="https://finanzasdigital.com/2019/10/dictamen-de-s-a-nacional-farmaceutica-sanfar-obligaciones-quirografarias-2019-i-oq-2019/" target="_blank" rel="noopener">Ver Dictamen de Calificación de Riesgo &#8211; Global Ratings SCR, C.A.</a></p>
<p>&nbsp;</p>
<p>Ver Prospecto de Calificación de Riesgo</p>
<p>&nbsp;</p>
<div class='heateor_sss_sharing_container heateor_sss_vertical_sharing heateor_sss_bottom_sharing' style='width:34px;left: -10px;top: 300px;-webkit-box-shadow:none;box-shadow:none;' data-heateor-sss-href='https://finanzasdigital.com/2019/10/sunaval-autoriza-oferta-publica-obligaciones-quirografarias-de-s-a-nacional-farmaceutica-sanfar/'><div class="heateor_sss_sharing_ul"><a class="heateor_sss_button_twitter" href="http://twitter.com/intent/tweet?via=finanzasdigital&text=Sunaval%20autoriza%20Oferta%20P%C3%BAblica%20de%20Obligaciones%20Quirografarias%20de%20S.A.%20Nacional%20Farmac%C3%A9utica%20%28SANFAR%29&url=https%3A%2F%2Ffinanzasdigital.com%2F2019%2F10%2Fsunaval-autoriza-oferta-publica-obligaciones-quirografarias-de-s-a-nacional-farmaceutica-sanfar%2F" title="Twitter" rel="nofollow noopener" target="_blank" style="font-size:32px!important;box-shadow:none;display:inline-block;vertical-align:middle"><span class="heateor_sss_svg heateor_sss_s__default heateor_sss_s_twitter" style="background-color:#55acee;width:30px;height:30px;border-radius:999px;display:inline-block;opacity:1;float:left;font-size:32px;box-shadow:none;display:inline-block;font-size:16px;padding:0 4px;vertical-align:middle;background-repeat:repeat;overflow:hidden;padding:0;cursor:pointer;box-sizing:content-box"><svg style="display:block;border-radius:999px;" focusable="false" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" width="100%" height="100%" viewBox="-4 -4 39 39"><path d="M28 8.557a9.913 9.913 0 0 1-2.828.775 4.93 4.93 0 0 0 2.166-2.725 9.738 9.738 0 0 1-3.13 1.194 4.92 4.92 0 0 0-3.593-1.55 4.924 4.924 0 0 0-4.794 6.049c-4.09-.21-7.72-2.17-10.15-5.15a4.942 4.942 0 0 0-.665 2.477c0 1.71.87 3.214 2.19 4.1a4.968 4.968 0 0 1-2.23-.616v.06c0 2.39 1.7 4.38 3.952 4.83-.414.115-.85.174-1.297.174-.318 0-.626-.03-.928-.086a4.935 4.935 0 0 0 4.6 3.42 9.893 9.893 0 0 1-6.114 2.107c-.398 0-.79-.023-1.175-.068a13.953 13.953 0 0 0 7.55 2.213c9.056 0 14.01-7.507 14.01-14.013 0-.213-.005-.426-.015-.637.96-.695 1.795-1.56 2.455-2.55z" fill="#fff"></path></svg></span></a><a class="heateor_sss_facebook" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Ffinanzasdigital.com%2F2019%2F10%2Fsunaval-autoriza-oferta-publica-obligaciones-quirografarias-de-s-a-nacional-farmaceutica-sanfar%2F" title="Facebook" rel="nofollow noopener" target="_blank" style="font-size:32px!important;box-shadow:none;display:inline-block;vertical-align:middle"><span class="heateor_sss_svg" style="background-color:#3c589a;width:30px;height:30px;border-radius:999px;display:inline-block;opacity:1;float:left;font-size:32px;box-shadow:none;display:inline-block;font-size:16px;padding:0 4px;vertical-align:middle;background-repeat:repeat;overflow:hidden;padding:0;cursor:pointer;box-sizing:content-box"><svg style="display:block;border-radius:999px;" focusable="false" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" width="100%" height="100%" viewBox="-5 -5 42 42"><path d="M17.78 27.5V17.008h3.522l.527-4.09h-4.05v-2.61c0-1.182.33-1.99 2.023-1.99h2.166V4.66c-.375-.05-1.66-.16-3.155-.16-3.123 0-5.26 1.905-5.26 5.405v3.016h-3.53v4.09h3.53V27.5h4.223z" fill="#fff"></path></svg></span></a><a class="heateor_sss_button_linkedin" href="http://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Ffinanzasdigital.com%2F2019%2F10%2Fsunaval-autoriza-oferta-publica-obligaciones-quirografarias-de-s-a-nacional-farmaceutica-sanfar%2F&title=Sunaval%20autoriza%20Oferta%20P%C3%BAblica%20de%20Obligaciones%20Quirografarias%20de%20S.A.%20Nacional%20Farmac%C3%A9utica%20%28SANFAR%29" title="Linkedin" rel="nofollow noopener" target="_blank" style="font-size:32px!important;box-shadow:none;display:inline-block;vertical-align:middle"><span class="heateor_sss_svg heateor_sss_s__default heateor_sss_s_linkedin" style="background-color:#0077b5;width:30px;height:30px;border-radius:999px;display:inline-block;opacity:1;float:left;font-size:32px;box-shadow:none;display:inline-block;font-size:16px;padding:0 4px;vertical-align:middle;background-repeat:repeat;overflow:hidden;padding:0;cursor:pointer;box-sizing:content-box"><svg style="display:block;border-radius:999px;" focusable="false" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" width="100%" height="100%" viewBox="0 0 32 32"><path d="M6.227 12.61h4.19v13.48h-4.19V12.61zm2.095-6.7a2.43 2.43 0 0 1 0 4.86c-1.344 0-2.428-1.09-2.428-2.43s1.084-2.43 2.428-2.43m4.72 6.7h4.02v1.84h.058c.56-1.058 1.927-2.176 3.965-2.176 4.238 0 5.02 2.792 5.02 6.42v7.395h-4.183v-6.56c0-1.564-.03-3.574-2.178-3.574-2.18 0-2.514 1.7-2.514 3.46v6.668h-4.187V12.61z" fill="#fff"></path></svg></span></a><a class="heateor_sss_whatsapp" href="https://api.whatsapp.com/send?text=Sunaval%20autoriza%20Oferta%20P%C3%BAblica%20de%20Obligaciones%20Quirografarias%20de%20S.A.%20Nacional%20Farmac%C3%A9utica%20%28SANFAR%29 https%3A%2F%2Ffinanzasdigital.com%2F2019%2F10%2Fsunaval-autoriza-oferta-publica-obligaciones-quirografarias-de-s-a-nacional-farmaceutica-sanfar%2F" title="Whatsapp" rel="nofollow noopener" target="_blank" style="font-size:32px!important;box-shadow:none;display:inline-block;vertical-align:middle"><span class="heateor_sss_svg" style="background-color:#55eb4c;width:30px;height:30px;border-radius:999px;display:inline-block;opacity:1;float:left;font-size:32px;box-shadow:none;display:inline-block;font-size:16px;padding:0 4px;vertical-align:middle;background-repeat:repeat;overflow:hidden;padding:0;cursor:pointer;box-sizing:content-box"><svg style="display:block;border-radius:999px;" focusable="false" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" width="100%" height="100%" viewBox="-6 -5 40 40"><path class="heateor_sss_svg_stroke heateor_sss_no_fill" stroke="#fff" stroke-width="2" fill="none" d="M 11.579798566743314 24.396926207859085 A 10 10 0 1 0 6.808479557110079 20.73576436351046"></path><path d="M 7 19 l -1 6 l 6 -1" class="heateor_sss_no_fill heateor_sss_svg_stroke" stroke="#fff" stroke-width="2" fill="none"></path><path d="M 10 10 q -1 8 8 11 c 5 -1 0 -6 -1 -3 q -4 -3 -5 -5 c 4 -2 -1 -5 -1 -4" fill="#fff"></path></svg></span></a><a class="heateor_sss_email" onclick="window.open('mailto:?subject=' + decodeURIComponent('Sunaval%20autoriza%20Oferta%20P%C3%BAblica%20de%20Obligaciones%20Quirografarias%20de%20S.A.%20Nacional%20Farmac%C3%A9utica%20%28SANFAR%29' ).replace('&', '%26') + '&body=' + decodeURIComponent('https%3A%2F%2Ffinanzasdigital.com%2F2019%2F10%2Fsunaval-autoriza-oferta-publica-obligaciones-quirografarias-de-s-a-nacional-farmaceutica-sanfar%2F' ), '_blank')" title="Email" rel="nofollow noopener" style="font-size:32px!important;box-shadow:none;display:inline-block;vertical-align:middle"><span class="heateor_sss_svg" style="background-color:#649a3f;width:30px;height:30px;border-radius:999px;display:inline-block;opacity:1;float:left;font-size:32px;box-shadow:none;display:inline-block;font-size:16px;padding:0 4px;vertical-align:middle;background-repeat:repeat;overflow:hidden;padding:0;cursor:pointer;box-sizing:content-box"><svg style="display:block;border-radius:999px;" focusable="false" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" width="100%" height="100%" viewBox="-4 -4 43 43"><path d="M 5.5 11 h 23 v 1 l -11 6 l -11 -6 v -1 m 0 2 l 11 6 l 11 -6 v 11 h -22 v -11" stroke-width="1" fill="#fff"></path></svg></span></a><a class="heateor_sss_button_instagram" href="https://www.instagram.com/finanzasdigital" title="Instagram" rel="nofollow noopener" target="_blank" style="font-size:32px!important;box-shadow:none;display:inline-block;vertical-align:middle"><span class="heateor_sss_svg" style="background-color:#53beee;width:30px;height:30px;border-radius:999px;display:inline-block;opacity:1;float:left;font-size:32px;box-shadow:none;display:inline-block;font-size:16px;padding:0 4px;vertical-align:middle;background-repeat:repeat;overflow:hidden;padding:0;cursor:pointer;box-sizing:content-box"><svg style="display:block;border-radius:999px;" version="1.1" viewBox="-10 -10 148 148" width="100%" height="100%" xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g><g><path d="M86,112H42c-14.336,0-26-11.663-26-26V42c0-14.337,11.664-26,26-26h44c14.337,0,26,11.663,26,26v44 C112,100.337,100.337,112,86,112z M42,24c-9.925,0-18,8.074-18,18v44c0,9.925,8.075,18,18,18h44c9.926,0,18-8.075,18-18V42 c0-9.926-8.074-18-18-18H42z" fill="#fff"></path></g><g><path d="M64,88c-13.234,0-24-10.767-24-24c0-13.234,10.766-24,24-24s24,10.766,24,24C88,77.233,77.234,88,64,88z M64,48c-8.822,0-16,7.178-16,16s7.178,16,16,16c8.822,0,16-7.178,16-16S72.822,48,64,48z" fill="#fff"></path></g><g><circle cx="89.5" cy="38.5" fill="#fff" r="5.5"></circle></g></g></svg></span></a></div><div class="heateorSssClear"></div></div>

Sunaval autoriza Oferta Pública de Obligaciones Quirografarias de S.A. Nacional Farmacéutica (SANFAR)